EBEllen Barton

Ellen Barton

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ellen Barton has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Physicians’ use of plain language during discussions of prostate cancer clinical trials with patients

    by Luke Thominet, Lauren M. Hamel, Fatmeh Baidoun, Tanina F. Moore, Ellen Barton, Elisabeth I. Heath, Michael Carducci, Dina Lansey, Susan Eggly


  • The influence of a question prompt list on patient-oncologist information exchange in an African-American population

    by Ellen Barton, Tanina Foster Moore, Lauren Hamel, Louis Penner, Terrance Albrecht, Susan Eggly


  • Do Community Members Have an Effective Voice in the Ethical Deliberation of a Behavioral Institutional Review Board?

    by Ellen Barton, Luke Thominet, Ruth Boeder, Sarah Primeau

    Using concepts and methods from technical and professional communication and linguistics, the authors conducted an observational study of the voice of community members (CMs) in the deliberation of a behavioral institutional review board (IRB). In the discourse of deliberation, they found that CMs had an effective voice in constructing the compliance of individual research protocols under IRB review. But they also found that CMs had an ineffective voice in representing their African-American community, particularly in their efforts to advocate for more consideration of minority research sites and subjects and a fuller consideration of minority community attitudes.


  • Open Access

    Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials

    by Susan Eggly, Lauren M. Hamel, Elisabeth Heath, Mark A. Manning, Terrance L. Albrecht, Ellen Barton, Mark Wojda, Tanina Foster, Michael Carducci, Dina Lansey, et al.

    Cancer clinical trials are essential for testing new treatments and represent state-of-the-art cancer treatment, but only a small percentage of patients ever enroll in a trial. Under-enrollment is an even greater problem among minorities, particularly African Americans, representing a racial/ethnic disparity in cancer care. One understudied cause is patient-physician communication, which is often of poor quality during clinical interactions between African-American patients and non-African-American physicians. Partnering Around Cancer Clinical Trials (PACCT) involves a transdisciplinary theoretical model proposing that patient and physician individual attitudes and beliefs and their interpersonal communication during racially discordant clinical interactions influence outcomes related to patients’ decisions to participate in a trial. The overall goal of the study is to test a multilevel intervention designed to increase rates at which African-American and White men with prostate cancer make an informed decision to participate in a clinical trial. Data collection will occur at two NCI-designated comprehensive cancer centers. Participants include physicians who treat men with prostate cancer and their African-American and White patients who are potentially eligible for a clinical trial. The study uses two distinct research designs to evaluate the effects of two behavioral interventions, one focused on patients and the other on physicians. The primary goal is to increase the number of patients who decide to enroll in a trial; secondary goals include increasing rates of physician trial offers, improving the quality of patient-physician communication during video recorded clinical interactions in which trials may be discussed, improving patients’ understanding of trials offered, and increasing the number of patients who actually enroll. Aims are to 1) determine the independent and combined effects of the two interventions on outcomes; 2) compare the effects of the interventions on African-American versus White men; and 3) examine the extent to which patient-physician communication mediates the effect of the interventions on the outcomes. PACCT has the potential to identify ways to increase clinical trial rates in a diverse patient population. The research can also improve access to high quality clinical care for African American men bearing the disproportionate burden of disparities in prostate and other cancers. Clinical Trials.gov registration number: NCT02906241 (September 8, 2016).


  • Development of a patient question prompt list to improve communication and clinical trial enrollment in a diverse patient population.

    by Lauren M. Hamel, Louis Penner, Elisabeth I. Heath, Dina Lansey, Michael Anthony Carducci, Terrance Lynn Albrecht, Ellen Barton, Mark A. Manning, Mark Wojda, Susan Eggly

    143 Background: Few patients, especially racial/ethnic minorities, enroll in clinical trials (CT), in part due to patient-oncologist communication. Question prompt lists (QPLs) improve communication, but have not been tested in CT discussions in a diverse patient population. We describe the development and acceptability of a theory-based QPL to improve communication and enrollment of White and Black men in prostate cancer CTs. Methods: Two existing QPLs were adapted by a team of communication scientists, psychologists, clinicians and patients. Guiding theories were the common ingroup identity model, which suggests people from different social groups can better achieve goals when they are on the same team, and patient-centered communication, which suggests that patient active participation improves clinical communication. The revised QPL included text to encourage patients to see themselves and their oncologist as a team, and 33 questions about CTs to encourage patients to participate actively in clinical interactions that include a CT discussion. To test acceptability, we recruited 15 Black or White men currently enrolled in a prostate cancer CT at an urban comprehensive cancer center. We asked patients to provide feedback on the QPL, to endorse which questions were most important, and for suggested improvements. Results: Patients participated anonymously. All patients said the QPL would be useful. Four patients reported liking the graphics/layout. Six patients reported liking the team text, but one commented that it was unnecessary. Three patients liked that the QPL included many questions, several of which they had not thought to ask when they discussed a CT with their oncologist. Ten patients endorsed the questions they thought were important to ask (M = 24 questions, SD = 9). The most frequently endorsed questions were what is already known about this treatment and how serious are the side effects? Conclusions: Patients found the QPL to be acceptable and useful. The QPL was revised according to patient feedback. We are testing the revised QPL's influence on patient-oncologist communication about CTs, patient understanding of CTs offered, and patient decisions to enroll in a CT.

  • Ethical or Unethical Persuasion?

    by Ellen Barton, Susan Eggly

    Based on a sample of 22 oncology encounters, this article presents a discourse analysis of positive, neutral, or negative valence in the presentation of three elements of informed consent—purpose, benefits, and risks—in offers to participate in clinical trials. It is found that physicians regularly present these key elements of consent with a positive valence, perhaps blurring the distinction between clinical care and clinical research in trial offers. The authors argue that the rhetoric of trial offers constructs and reflects the complex relationships of two competing ethical frameworks—contemporary bioethics and professional medical ethics—both aimed at governing the discourse of trial offers. The authors consider the status of ethical or unethical persuasion within each framework, proposing what is called the best-option principle as the ethical principle governing trial offers within professional medical ethics.


  • Judith Felson Duchan and Dana Kovarsky (eds.), Diagnosis as cultural practice

    by Ellen Barton

    Judith Felson Duchan and Dana Kovarsky (eds.), Diagnosis as cultural practice. Berlin & New York: Mouton de Gruyter, 2005. Pp. x, 307, Pb. $32.95. This volume contributes to a growing body of literature on diagnosis as sociocultural and interactional practices in medicine particularly and society generally. Diagnosis is typically defined solely in terms of expertise within a biomedical model: “the art or act of identifying a disease from its signs and symptoms” (Medline Plus 2005), a definition that incorporates medicine's deeply ambivalent attitude toward lay knowledge with its distinction between symptoms subjectively reported by patients and signs objectively observed by physicians. In the first chapter of this volume, however, the editors set out a broader social model of diagnosis as (i) a way of experiencing, doing, and thinking that is pervasive in Western culture, (ii) constructed by lay people as well as professional experts, (iii) socially situated and culturally sensitive, (iv) a process and product of social interaction and social discourse, that (v) can have a life altering impact on those diagnosed (p. 1).

  • Situating end-of-life decision making in a hybrid ethical frame

    by Ellen Barton

    Good communication in EOL (end-of-life) discussions is described at a general level in the literature, but there are few studies of EOL discussions at the level of interaction, with data drawn from the actual talk between physicians and families. In this article I present a discourse analysis of EOL discussions from an American ICU (intensive care unit) where the decision to withdraw life support is situated in a hybrid ethical frame co-constructed as the final phase of the EOL discussion. In Mishler's (1984) terms, the final phase of the EOL discussion merges the voice of medicine and the voice of the lifeworld, with both physicians and families initiating, developing, and repeating particular topics that encompass not only the logistics of death but also the ethics of the end-of-life decision. Physicians index their ethical accountability in terms of medical futility, and families express their accountability in terms of an ethics of consciousness. The hybrid ethical frame that is co-constructed ultimately centers upon consensus that the 'right' decision has been made from both ethical perspectives.


  • Structure and variation in end-of-life discussions in the Surgical Intensive Care Unit

    by Ellen Barton, Matthew Aldridge, Thomas Trimble, Justin Vidovic

    The research reported here is an exploratory discourse analysis of a corpus of six end-of-life discussions in a Surgical Intensive Care Unit (SICU), describing the structure and variations of the four phases of an end-of-life discussion in terms of the function of each of these phases: the Opening (Phase 1), Description of Current Status (Phase 2), Holistic Decision Making (Phase 3), and Logistics of Dying (Phase 4). Of particular interest is Phase 2, in which the presentation of medical information culminates in an inferential summary statement that functions to establish the patient's status as terminal. We argue that it is Phase 2 that is crucial in the functional progression of an end-of-life discussion toward a decision to move from therapeutic to palliative care, since it is in Phase 2 that physicians and families interactionally achieve a consensus that allows a decision to withdraw or withhold further treatment, including life support, which would be futile and only prolong the patient's suffering. We show how two of the end-of-life discussions in the corpus that did not establish the terminal status of the patient in Phase 2 did not move to decision making in Phase 3.